Author Archives: admin

F1000 Commentary: Attitudes towards “disorders of sex development” nomenclature among affected individuals.

Posted on July 14, 2017 by

Johnson EK, Rosoklija I, Finlayson C, Chen D, Yerkes EB, Madonna MB, Holl JL,Baratz AB, Davis G, Cheng EY. J Pediatr Urol 2017 May 08 DOI: 10.1016/j.jpurol.2017.03.035 Abstract Introduction Although now commonly used in medicine, the updated “disorders of sex development” (DSD) nomenclature formally introduced in 2006 has never been … Continue reading →

Posted in F1000 Archives | Tagged | Leave a comment

Developing Multidisciplinary Teams

Posted on July 11, 2013 by

Advocacy Advisory Network member Mary Elizabeth Moran and Katarina Karkazis have recently published an article: “Developing a Multidisciplinary Team for Disorders of Sex Development: Planning, Implementation, and Operation Tools for Care Providers”. In this article, the authors discuss how a multidisciplinary … Continue reading →

Posted in DSD Research Highlights | Leave a comment

F1000 Commentary: Disorders of Sex Development-When and How to Tell the Patient

Posted on December 12, 2011 by

Austin J, Tamar-Mattis A, Mazur T, Henwood MJ, Rossi WC: Pediatr Endocrinol Rev. 2011; 8:213-7 DOI: 10.3410/f.13398997.14768117 Abstract Physicians and other providers are often confronted with difficult decisions in the area of disclosure. This article examines a hypothetical situation relevant to … Continue reading →

Posted in F1000 Archives | Tagged , , , , , , , , , | Leave a comment